Menlo Ventures Management
Latest statistics and disclosures from Menlo Ventures Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CHYM, SPCX, Scribe Therapeutics, BRZE, SNTI, and represent 100.00% of Menlo Ventures Management's stock portfolio.
- Added to shares of these 2 stocks: SPCX (+$14M), Scribe Therapeutics.
- Started 2 new stock positions in Scribe Therapeutics, SPCX.
- Reduced shares in these 1 stock: CHYM (-$240M).
- Menlo Ventures Management was a net seller of stock by $-224M.
- Menlo Ventures Management has $241M in assets under management (AUM), dropping by -32.69%.
- Central Index Key (CIK): 0001911541
Tip: Access up to 7 years of quarterly data
Positions held by Menlo Ventures Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Menlo Ventures Management
Menlo Ventures Management holds 5 positions in its portfolio as reported in the September 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Chime Finl Com Shs Cl A (CHYM) | 93.5 | $225M | -51% | 8.4M | 26.64 |
|
| Space Exploration Techn Corp Class A Com Stk (SPCX) | 5.7 | $14M | NEW | 92k | 150.86 |
|
| Scribe Therapeutics | 0.7 | $1.8M | NEW | 98k | 18.41 |
|
| Braze Com Cl A (BRZE) | 0.0 | $116k | 4.6k | 25.10 |
|
|
| Senti Biosciences Holdings I Com New (SNTI) | 0.0 | $11k | 36k | 0.31 |
|
Past Filings by Menlo Ventures Management
SEC 13F filings are viewable for Menlo Ventures Management going back to 2026
- Menlo Ventures Management 2026 Q3 filed Nov. 6, 2026
- Menlo Ventures Management 2026 Q2 filed Aug. 10, 2026
- Menlo Ventures Management 2026 Q1 filed May 15, 2026